marijuana stock news

Form 8-K for 22ND CENTURY GROUP, INC.

9-Jan-2015

Other Events, Financial Statements and Exhibits

Item 8.01. Other Events.On January 9, 2015, 22nd Century Group, Inc. (the “Company”) filed with the Securities and Exchange Commission a prospectus supplement dated January 9, 2015, to the prospectus dated June 5, 2014, filed as part of the Company’s effective registration statement on Form S-3 (SEC File No. 333-195386). The prospectus supplement relates to the offer and sale of up to 300,000 shares of the Company’s common stock covered by the registration statement.

Item 9.01. Financial Statements and Exhibits.(d) The following exhibits are being filed herewith:

Exhibit 5.1 Opinion of Foley & Lardner LLP
Exhibit 23.1 Consent of Foley & Lardner LLP (included in Exhibit 5.1)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Fire & Flower Holdings Corp. (FFLWF) and Hifyre Announce Proposed Acquisition of PotGuide

Fire & Flower and Hifyre Announce Proposed Acquisition of PotGuide Fire &…

GrowGeneration Corp. (GRWG) to Host Earnings Call

GrowGeneration Corp. to Host Earnings Call GrowGeneration Corp. (NASDAQ:GRWG) will be discussing…

22nd Century Group, Inc. (XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company

22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company…

AbbVie Inc. (ABBV) Announces First Provincial Reimbursement for VENCLEXTA® (venetoclax) with Obinutuzumab

AbbVie Announces First Provincial Reimbursement for VENCLEXTA® (venetoclax) with Obinutuzumab for Patients…